# Does Axillary Nerve and Inferior Capsule Release Add Extra Benefit in Treating Patients With Adhesive Capsulitis

> **NCT05921539** · NA · UNKNOWN · sponsor: **Taipei Veterans General Hospital, Taiwan** · enrollment: 72 (estimated)

## Conditions studied

- Adhesive Capsulitis of Shoulder

## Interventions

- **DRUG:** steroid hydrodilatation
- **DRUG:** axillary nerve injection

## Key facts

- **NCT ID:** NCT05921539
- **Lead sponsor:** Taipei Veterans General Hospital, Taiwan
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-01
- **Primary completion:** 2025-03-01
- **Final completion:** 2025-03-01
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2023-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05921539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05921539, "Does Axillary Nerve and Inferior Capsule Release Add Extra Benefit in Treating Patients With Adhesive Capsulitis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05921539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*